Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dauntless who wrote (2548)	2/26/1998 11:40:00 AM
From: clochard	Read Replies (1) \| Respond to of 7041

What if Zonagen is granted a patent for Vasomax AND Immumax? What if Zonagen is listed on the NYSE? What if Zonagen opens a chain of ED clinics? What if Zonagen buys Glaxo and pays for it with a stock offering? What if Zonagen moves its headquarter from Texas to Silicon Valley?

To: Dauntless who wrote (2548)	2/26/1998 12:01:00 PM
From: Linda Kaplan	Respond to of 7041

Guys and Gals, I have a copy of the FORTUNE article. It's seven pages and very negative regarding Zonagen. Page 1: It's also a tale of how a Texas startup called Zonagen rode the hype to a remarkable valuation, wooing investors with press releases that omitted disappointing clinical results and misled stockholders about its patent protection. Its story provides a rare look at how the best face is put on new medical treatments--and how the investment community can be taken in. More later. I have to do some other things. Linda